From the Coalition on Abortion/Breast Cancer Press Release, September 26, 2005:
"Ladies, take cover! Andrew Von Eschenbach was named acting commissioner of the U.S. Food and Drug Administration (FDA) on Friday," warned Karen Malec, president of the Coalition on Abortion/Breast Cancer. "The FDA had a commissioner who could resist political pressure. His abrupt resignation after two months on the job creates the impression that the Bush Administration couldn't take the heat from the abortion and the pharmaceutical industries. The industries want Plan B (morning-after pill) made available for over-the-counter sales.""Von Eschenbach is no friend of women," warned Malec, a cancer survivor. "He's a friend of the anti-woman abortion and pharmaceutical industries."
LifeNews.com has the story.
For more information on the abortion/breast cancer link go here.
Cross-posted from Choose Life.
We also posted that, while Von Eschenbach was the head of NCI, NCI buried the findings of a China study they themselves funded for five years that found there were in fact links between induced abortion and increased risks of breast cancer. It was presented in an obscure conference abstract but otherwise buried by NCI while on von Eschenbach's watch:
http://afterabortion.blogspot.com/2005/09/andrew-c.html